Monosodium Phosphate 2-hydrate is now available with CEP
Dr. Paul Lohmann® recently received a CEP (Certificate of Suitability to the European Pharmacopoeia) for Monosodium Phosphate 2-hydrate, which enables a customer to register a drug in several countries in a cost-saving and simplified way. Since this Monosodium Phosphate 2-hydrate meets the purity requirements of Ph.Eur. and has a low endotoxin content, it is ideally suited for oral and parenteral dosage forms.
In the pharmaceutical industry, Monosodium Phosphate 2-hydrate is used either as active pharmaceutical ingredient (API) against hypophosphataemia and constipation or as an excipient for buffering reasons. In addition, it is widely used in biomanufacturing processes as it is part of phosphate buffered saline (PBS) and is essential for cell culture media as well as for purification and final liquid formulation.
Related News
-
News Understanding the Benefits and Advances of Cleanroom Technology
In an industry where precision and sterility are crucial concerns, cleanrooms play a vital role in maintaining the integrity of pharmaceutical products like drugs, vaccines, and other medical products. So, what is a cleanroom?
-
News Women in Pharma: The Final Chapter of 2025
Our monthly Women in Pharma series highlights the influential lives and work of impactful women working across the pharmaceutical industry, and how the industry can work towards making the healthcare industry and workplace more equitable and ... -
News Introducing the Pharmaceutical Sustainability Ecosystem from CPHI
The Sustainability Collective from CPHI unveils the groundbreaking Pharmaceutical Sustainability Ecosystem to drive pharmaceutical knowledge sharing, connection, and collaboration in order to change the face of sustainability in pharmceutical... -
News Navigating Cross-Border Pharmaceutical Logistics: Strategies for a More Resilient Supply Chain
This is a feature article written by Nick Fryer, Vice President of Marketing, Sheer Logistics
-
News A Day in the Life of a Director of Business Development
In this Day in the Life of interview, Thomas Hauser, Director of Business Development at Tjoapack. Thomas has spent nearly 30 years in the pharmaceutical industry and describes how he still finds curiosity and excitement in the bigger picture of global... -
News PhRMA trade association issues comments on Section 232 investigation
The Pharmaceutical Research and Manufacturers of America (PhRMA), an American trade association representing groups in the pharmaceutical industry, issued a letter on May 6, 2026 to the Department of Commerce regarding the Section 232 National Security... -
News Pharmaceutical Packaging Market Prospects: Shifting regional policies
The pharmaceutical packaging industry is experiencing significant transformation in 2025, driven by regulatory changes, supply chain challenges, and sustainability initiatives. The US BIOSECURE Act, passed through the House of Representatives in Septem... -
News Say hello to the CPHI Exhibitor Spotlight!
We’re kicking off a brand-new series where we shine the spotlight on some of the amazing companies gearing up to shake things up at CPHI Americas 2025 this May! The first company in our spotlight is TAPI, who are set to make a splash at its ve...